Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00628147 · ClinicalTrials.gov registry record · Phase 4

Clinical Evaluation of Narrow Band Imaging Colonoscope

A Phase 4 study of Colonic Neoplasms, sponsored by VA Palo Alto Health Care System.

Completed
Registry status
Phase 4
Development phase
284
Enrollment target
1
Study location

NCT00628147 is a Phase 4 study of Colonic Neoplasms that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 284 participants, below the 1,503-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00628147, a Phase 4 study of Colonic Neoplasms, has completed, sponsored by VA Palo Alto Health Care System.

COMPLETED
Registry status
Phase 4
Development phase
284 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine if colonoscopic examination using a colonoscope with a narrow band imaging light is more effective at detecting polyps compared to a colonoscope with standard full spectrum white light.

Conditions Studied

Interventions

  • DEVICE Narrow band imaging colonoscope

Study Locations (1)

California

  • VAPaloAltoHCS - Palo Alto

Trial Details

FieldValue
Enrollment Target 284 participants
Start Date 2006-01
Est. Completion 2007-03
Phase Phase 4

Sponsor

VA Palo Alto Health Care System

34 total trials

What the Registry Record Tells You About NCT00628147

The ClinicalTrials.gov registry entry for NCT00628147 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 284 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,503-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (81% lower). The listed sponsor is VA Palo Alto Health Care System, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colonic Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Narrow band imaging colonoscope is the first listed.

NCT00628147 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00628147 about?

NCT00628147 is a clinical study titled "Clinical Evaluation of Narrow Band Imaging Colonoscope". The purpose of the study is to determine if colonoscopic examination using a colonoscope with a narrow band imaging light is more effective at detecting polyps compared to a colonoscope with standard full spectrum white light.

What is the current status of trial NCT00628147?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 284 participants. The study started on 2006-01. Estimated completion is 2007-03.

What conditions does trial NCT00628147 study?

This clinical trial studies the following conditions: Colonic Neoplasms.

What interventions are being tested in trial NCT00628147?

The interventions under investigation include: Narrow band imaging colonoscope (DEVICE).

Who is sponsoring clinical trial NCT00628147?

This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00628147 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colonic Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.